HbA1c biosensor [ 2014 - 2018 ]

Research Grant

Researchers: Prof John Gooding (Principal investigator)

Brief description A portable device that can measure glycosylated haemoglobin (HbA1c) in the home will be developed. HbA1c is an important biomarker of the average blood glucose levels over the preceding three months and hence guides a diabetic regarding their blood glucose treatment regime. A 1% decrease in HbA1c levels is associated with a dramatic decrease in chronic health complications from diabetes. The HbA1c meter that will be developed will be able to operate with existing glucose meter technologies.

Funding Amount $AUD 587,164.12

Funding Scheme Development Grants

Notes Development Grant